A new focal therapy technique has proven highly effective at treating prostate cancer with patients remaining cancer-free a decade later.
A new breakthrough offers hope for healing previously intractable lung diseases.
A new cholesterol-fighting drug approval provides additional treatment options for patients.
FDA approval of a new cholesterol pill expands treatment options for patients.
Real-world safety data confirms the approved ALS drug continues to be well-tolerated in patients.
Q32's alopecia drug study succeeded, offering hope to millions suffering from hair loss.
Futura Medical's Eroxon treatment and WSD4000 device represent advances in addressing sexual health conditions.
A medical breakthrough significantly improves a patient's quality of life and health outcomes.
Two boys with rare Hunter syndrome find hope and healing through a new FDA-approved treatment.
Palvella Therapeutics advances toward FDA approval for QTORIN™, a potential new treatment for microcystic lymphatic malformations.
FDA approval of a new psoriasis treatment for children as young as 2 years old offers families a new therapeutic option for this chronic condition.
Viridian has received FDA approval for Lumvoa, a new treatment offering patients additional therapeutic options.
First medicine approved under new 'fast access' procedure, accelerating patient access to needed treatments.
FDA clears an investigational remyelinating agent for multiple sclerosis treatment.
A weight-loss drug has been approved by Health Canada that can help treat sleep apnea, offering patients a new therapeutic option.
A new drug helps preserve muscle health in patients using GLP-1 weight-loss treatments, improving quality of life.
A patient given just three years to live in 1998 has thrived for over two decades, offering hope to others.
The FDA has approved Moderna's innovative mRNA-based flu vaccine, expanding protection against seasonal influenza.
A new diabetes drug approved by the NHS is heralding a transformative new era in diabetes treatment.
Regeneron's drug application for cemdisiran is accepted for FDA and EMA review, advancing treatment options for patients.
A newly approved species of fly offers an innovative biological approach to wound healing and treatment.
A groundbreaking Parkinson's disease treatment is transforming patients' lives with lasting improvements.
UniQure is moving forward with a promising gene therapy for Huntington's disease after FDA alignment.
A new antibiotic treatment for complicated urinary tract infections has received FDA approval.
Aethlon Medical's Hemopurifier advances through final trial stages offering hope for critically ill patients.
FDA accepts a new drug application for cenobamate oral suspension, advancing seizure disorder treatment.
FDA acceptance of Gilead's new drug application represents progress toward bringing a new therapeutic option to patients.
Belite Bio advances toward FDA approval for an oral therapy treating Stargardt disease, a previously untreatable retinal condition.
FDA approves a new treatment option for kidney cancer patients at risk of recurrence.
Lupus patients achieve remission through pioneering gene therapy trial, offering life-changing hope for autoimmune disease sufferers.
Weight-loss drug Wegovy becomes available in pill form in the UK, expanding patient access.
Emergency FDA approval brings screwworm treatment to pets in need.
FDA approval of Ebglyss provides patients with a new eczema treatment option.
Wisconsin epilepsy research could help patients achieve seizure-free lives.
More cancer patients are living longer as targeted drug therapies continue to improve survival rates.
FDA approval of a new orally disintegrating tablet formulation offers patients greater treatment flexibility for chronic myeloid leukemia.
InnoCare's new drug application acceptance marks progress toward bringing a new treatment to patients.
FDA approves Hepcludex as the first-ever treatment for hepatitis D, offering hope to patients with limited options.
A new targeted cancer therapy receives priority review status, accelerating its path to patients in need.
A father celebrates his son's ability to access a new life-changing drug, bringing hope to families.
FDA approval of an innovative kidney stone treatment developed through biomedical engineering offers patients a new solution.
New medication for Tourette Syndrome shows promise in Phase III clinical trials.
A novel nightly pill for sleep apnea has shown strong trial results and is being fast-tracked toward FDA approval.
The Miami CFAR Symposium showcases major breakthroughs in HIV treatment and cure research that are transforming the fight against the disease.
First-ever weekly basal insulin approved by FDA simplifies diabetes management for patients.
Retatrutide clinical trial shows dramatic weight loss results, offering a promising new treatment option.
Bayer's KERENDIA receives FDA priority review for treating kidney disease in adults with type 2 diabetes.
Five FDA first-in-class drug approvals in 2026 bring innovative new treatment mechanisms to patients.
Lilly's experimental weight loss drug shows significant results, helping patients lose substantial amounts of weight.
Vertex's pain relief drug suzetrigine advances with Health Canada review for treating moderate-to-severe acute pain.
FDA approves a new blood pressure medication providing patients with an additional hypertension management option.
FDA approval of the first aldosterone synthase inhibitor provides a new treatment option for hypertension patients.
AstraZeneca's blood pressure drug receives US approval, offering patients another treatment option.
AstraZeneca's new blood pressure pill opens a new drug class for hypertension treatment.
Innovative cancer immunotherapy receives regulatory approval for clinical development.
First major stomach cancer drug approved for NHS use in a decade offers patients a significant therapeutic advance.
Regenxbio's positive new data brings hope closer to patients with Duchenne muscular dystrophy seeking gene therapy treatment.
FDA advances personalized, patient-centered care approaches offering more tailored treatment options.
FDA approval expands treatment options available to Alzheimer's disease patients.